Bokf, Na Biogen Inc. Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Biogen Inc. stock. As of the latest transaction made, Bokf, Na holds 24,209 shares of BIIB stock, worth $3.61 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

24,209

Previous 24,828 2.49%

Holding current value

$3.61 Million

Previous $5.76 Million 18.47%

% of portfolio

0.08%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $117,034 - $146,579	-619 Reduced 2.49%	24,209 $4.69 Million
Q2 2024 Aug 07, 2024	SELL	$190.52 - $236.72 $184,804 - $229,618	-970 Reduced 3.76%	24,828 $5.76 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $1.81 Million - $2.29 Million	-8,556 Reduced 24.91%	25,798 $5.56 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $1.92 Million - $2.31 Million	-8,607 Reduced 20.03%	34,354 $8.89 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $3.95 Million - $4.46 Million	15,583 Added 56.92%	42,961 $11 Million
Q2 2023 Aug 21, 2023	BUY	$275.25 - $318.06 $1.49 Million - $1.73 Million	5,424 Added 24.71%	27,378 $7.8 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $1.77 Million - $2.02 Million	-6,894 Reduced 23.9%	21,954 $6.1 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $37,108 - $45,087	147 Added 0.51%	28,848 $7.99 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.83 Million - $2.53 Million	9,421 Added 48.86%	28,701 $7.66 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $13,502 - $16,057	-72 Reduced 0.37%	19,280 $3.93 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $3,875 - $4,882	-20 Reduced 0.1%	19,352 $4.08 Million
Q4 2021 Mar 11, 2022	SELL	$223.92 - $287.77 $1.6 Million - $2.05 Million	-7,135 Reduced 26.92%	19,372 $4.65 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $2.1 Million - $2.74 Million	7,419 Added 38.87%	26,507 $7.5 Million
Q1 2021 Apr 21, 2021	SELL	$242.95 - $284.63 $366,611 - $429,506	-1,509 Reduced 7.33%	19,088 $5.34 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $1.07 Million - $1.62 Million	4,546 Added 28.32%	20,597 $5.04 Million
Q3 2020 Oct 30, 2020	BUY	$264.77 - $305.71 $1.27 Million - $1.47 Million	4,806 Added 42.74%	16,051 $4.55 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $1.97 Million - $2.61 Million	7,629 Added 210.98%	11,245 $3.01 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $173,139 - $219,629	644 Added 21.67%	3,616 $1.14 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $83,182 - $114,938	-378 Reduced 11.28%	2,972 $882,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $502,068 - $563,118	-2,309 Reduced 40.8%	3,350 $780,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $110,522 - $121,826	-504 Reduced 8.18%	5,659 $1.32 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $1.79 Million - $2.81 Million	-8,282 Reduced 57.33%	6,163 $1.46 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $416,914 - $528,066	-1,497 Reduced 9.39%	14,445 $4.35 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.09 Million - $1.42 Million	-3,708 Reduced 18.87%	15,942 $5.63 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $771,529 - $919,502	2,996 Added 17.99%	19,650 $5.7 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $296,808 - $419,785	1,141 Added 7.36%	16,654 $4.56 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $3,076 - $3,445	-10 Reduced 0.06%	15,513 $4.94 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $61,009 - $71,542	217 Added 1.42%	15,523 $4.86 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,306	15,306 $4.15 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account